Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M3,240Revenue $M3,029Net Margin (%)-2.4Z-Score0.4
Enterprise Value $M7,244EPS $-1.1Operating Margin %4.5F-Score3
P/E(ttm))0Cash Flow Per Share $11.8Pre-tax Margin (%)-4.4Higher ROA y-yN
Price/Book2.210-y EBITDA Growth Rate %0Quick Ratio1.7Cash flow > EarningsY
Price/Sales1.15-y EBITDA Growth Rate %0Current Ratio2.2Lower Leverage y-yN
Price/Cash Flow1.6y-y EBITDA Growth Rate %1.8ROA % (ttm)-1.0Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-3.4Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M82.6ROI % (ttm)-6.6Gross Margin Increase y-yN

Gurus Latest Trades with ALR

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ALRMario Gabelli 2014-03-31 Add0.01%$33.99 - $39.34
($36.55)
$ 38.596%Add 646.65%79,145
ALRMario Gabelli 2012-06-30 Reduce$17.98 - $25.97
($20.85)
$ 38.5985%Reduce -25.93%10,000
ALRSeth Klarman 2012-06-30 Sold Out -0.12%$17.98 - $25.97
($20.85)
$ 38.5985%Sold Out0
ALRSeth Klarman 2012-03-31 Reduce-1.3%$22.21 - $26.64
($22.87)
$ 38.5969%Reduce -93.12%137,700
ALRMario Gabelli 2011-12-31 Reduce$18.51 - $26.43
($23.09)
$ 38.5967%Reduce -27.03%13,500
ALRSeth Klarman 2011-12-31 Reduce-0.72%$18.51 - $26.43
($23.09)
$ 38.5967%Reduce -35.48%2,000,000
ALRDavid Dreman 2011-12-31 Sold Out -0.53%$18.51 - $26.43
($23.09)
$ 38.5967%Sold Out0
ALRGeorge Soros 2011-06-30 Sold Out $33.98 - $41
($38.19)
$ 38.591%Sold Out0
ALRGeorge Soros 2011-03-31 Reduce$36.17 - $40.32
($38.34)
$ 38.591%Reduce -29.29%14,000
ALRMario Gabelli 2011-03-31 Reduce-0.03%$36.17 - $40.32
($38.34)
$ 38.591%Reduce -77.58%18,500
ALRSeth Klarman 2010-12-31 Add3.38%$28.14 - $36.39
($31.64)
$ 38.5922%Add 106.67%3,100,000
ALRGeorge Soros 2010-12-31 Add$28.14 - $36.39
($31.64)
$ 38.5922%Add 45.59%19,800
ALRSeth Klarman 2010-09-30 Buy 2.81%$26.5 - $31.29
($29.09)
$ 38.5933%New holding, 1500000 sh.1,500,000
ALRDavid Dreman 2010-09-30 Buy 0.76%$26.5 - $31.29
($29.09)
$ 38.5933%New holding, 1067385 sh.1,067,385
ALRMario Gabelli 2010-09-30 Buy 0.01%$26.5 - $31.29
($29.09)
$ 38.5933%New holding, 82500 sh.82,500
ALRGeorge Soros 2010-09-30 Buy 0.01%$26.5 - $31.29
($29.09)
$ 38.5933%New holding, 13600 sh.13,600
ALRGeorge Soros 2009-09-30 Buy 0.02%$30.69 - $40.79
($35.24)
$ 38.5910%New holding, 23306 sh.23,306
ALRDavid Dreman 2009-03-31 Buy 0.32%$20.9 - $28.75
($24.6)
$ 38.5957%New holding, 692293 sh.692,293
ALRRon Baron 2008-09-30 Add0.06%$29.8 - $35.7
($32.9)
$ 38.5917%Add 42.86%1,000,000
ALRGeorge Soros 2008-06-30 Sold Out -0.03%$31.9 - $36.94
($34.5)
$ 38.5912%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ALR is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
ALR Mario Gabelli 2014-03-3179,1450.10.02+646.65%
Premium Most recent portfolio changes are included for Premium Members only!


ALR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Torchilin KateVP, Connected Health 2013-12-11Sell8,547$33.7316.31view
HEMPEL PAUL TSVP Ethics & Compliance 2013-11-13Sell4,576$33.7416.27view
Teitel DaveCFO 2013-08-15Sell10,000$31.7323.64view
Cotton Michael LesterGlobal Pres, Health Mgmt 2013-08-05Sell12,500$33.8216view
Cotton Michael LesterGlobal Pres, Health Mgmt 2013-05-31Sell8,750$25.8651.7view
Post JimPresident, Acute Care 2013-03-07Sell1,075$23.3767.86view
QUELCH JOHNDirector 2013-03-05Sell20,220$23.4967.01view
EYLENBOSCH HILDEPresident, Alere International 2013-03-01Sell2,391$22.6972.9view
Post JimPresident, Alere NA 2012-08-23Sell840$18.77109view
TOOHEY DAVIDPresident, Intl Bus. Operation 2012-08-14Sell151$18.28114.61view

Press Releases about ALR :

    Quarterly/Annual Reports about ALR:

    News about ALR:

    Articles On GuruFocus.com
    Corsair Capital's Investment Thesis on Alere Inc. Jan 23 2014 
    Private Capital Management Sells Update Nov 27 2013 
    Performance - 11/15/2013 Nov 17 2013 
    Microcap Man Chuck Royce Reveals Top New Stock Buys Feb 07 2013 
    5 Resilient Biotech Stocks to Buy for 2012 Feb 28 2012 
    Are Regional Banks Free from European Exposure? Jan 27 2012 
    Alere Inc.: Foreign Currency Translations and the Euro Dec 21 2011 
    Alere, Inc ,Foreign Currency Translations and the Euro. Dec 21 2011 
    Diamond Hill Capital's Top 5 Third Quarter New Buys Oct 21 2011 
    Seth Klarman's Top 5 Picks: VSAT, THRX, NWS, CSE, ALR Mar 11 2011 


    More From Other Websites
    Neogen Q4 Earnings Lag Estimates but Up Y/Y on Higher Revenues Jul 23 2014
    Alere Earns Ethical and Quality Certification for Educational Anticoagulation Website Jul 21 2014
    Alere's Diagnostic Test Shows Accurate HIV Detection in Infants Jul 15 2014
    New Alere™ q Point-of-Care Early Infant Diagnosis Test Prototype Accurately Detects HIV in Infants... Jul 14 2014
    New Alere™ q Point-of-Care Early Infant Diagnosis Test Prototype Accurately Detects HIV in Infants... Jul 14 2014
    Alere could be worth $60 in a takeover, says Canaccord Jul 10 2014
    ALERE INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jul 07 2014
    Alere Announces Management Transition Jul 01 2014
    Alere CEO, other top executives resign in overhaul Jul 01 2014
    ALERE INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial... Jul 01 2014
    Alere Announces Management Transition Jul 01 2014
    Alere Opted Out of UK IPO for Unit Jun 19 2014
    Coopersmith Capital sends letter to Alere Chairman Gregg Powers Jun 19 2014
    [$$] Alere Won't Pursue U.K. IPO for Unit Jun 18 2014
    Alere Opts Not to Pursue Initial Public Offering by BBI Diagnostics Group plc Jun 18 2014
    FDA Nod for Alere's Influenza A & B Test Jun 17 2014
    Alere Receives FDA Clearance for Alere™ i Influenza A and B Test Jun 16 2014
    ALERE INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Submission of Matters to... Jun 05 2014
    Alere Inc. Secures Important Permissions for Previously Announced Transaction Involving BBI... Jun 05 2014
    [$$] SEC Drops Insider-Trading Case Against Atlanta Businessman Jun 04 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide